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LYTIC ANTIBODIES ELICITED BY TRYPANOSOMA CRUZI INFECTION 
RECOGNIZE EPITOPES PRESENT ON BOTH BLOODSTREAM 
TRYPOMASTIGOTE AND EPIMASTIGOTE FORMS OF PARASITE. 
Ham mi A . TAKEHARA, Diva F. CARDOSO, Ana M.M. da SILVA & I. MOTA 
SUMMARY 
Sera of Chaga 's disease patients containing anti-T. cruzi lytic antibodies were 
submitted to affinity chromatography using Sepharose 4B conjugated with antigen 
extracted from epimastigote or trypomastigote forms of the parasite. Epimastigotes 
were obtained from culture at the exponential growth phase and the trypomastigotes 
from blood of infected and immunosuppressed mice. Antigen of both parasite 
forms was obtained by sonication of the parasites followed by cemrifugation. Both 
antigens were then conjugated to activated Sepharose 4B. Affinity chromatography 
was performed by passing sera from chagasic patients through an immunoadsorbent 
column containing either epimastigote or t rypomasugote antigens. Antibodies 
bound to the column were eluted with cold 0,2 M glycine buffer pH 2,8. The eluted 
antibodies were analysed regarding their isotype and lytic activity. The results 
showed that anti-T. cruzi lytic antibodies present in sera from chagasic patients are 
mainly located in the IgG isotype and recognize epitopes present in both 
trypomastigote and epimastigote forms. A brief report of this work has already been 
published 1 2 . 
KEY WORDS: Lytic antibody; Trypanosoma cruzi 
INTRODUCTION 
Chagas's disease is a complex clinical 
entity due to infection of man by an 
intracellular protozoan, Trypanosoma cruzi. 
which is transmitted by blood sucking insects. 
T. cruzi has a complex life cycle and exists 
in different forms: the epimastigotes multiply-
ing within the insect gut; the metacyclic 
trypomastigotes that are the infective forms in 
the invertebrate host; the amastigote multi-
plicative stage form within the mammalian cells 
and the trypomastigote form that circulates in 
the bloodstream of the vertebrate host. 
Following infection with T. cruzi the 
immune system of the host responds with the 
formation of specific antibodies that are able to 
cause lysis of the trypomastigote forms in the 
presence of complement 3 . These antibodies are 
easily induced by infection with the parasite but 
are hardly induced by immunization with dead 
parasites and their presence in the infected host 
has been correlated with res i s tance 5 6 . The 
epitopes recognized by lytic antibodies are 
certainly present in the membrane of the 
trypomastigote but their presence in other 
forms of the parasite has not been investigated. 
We present here results suggesting that 
lytic antibodies recognize epitopes present on 
both trypomastigote and epimastigote forms of 
the parasite. 
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MATERIAL A N D METHODS 
Serum from chagasic patients: serum was 
obtained from blood collected from patients in 
the chronic phase of Chagas ' disease with 
positive specific serological tests (complement 
fixation, haemagglutination and immunofluo-
rescence). All sera from chagasic patients were 
inactivated at 56°C for 1 hour before use. 
When not used immediately the samples were 
stored at -20°C. Serum samples from 16 
patients were studied. In some experiments the ' 
sera were tested individually (CS 1 to CS 5) or 
in pools ( P I : CS 6, 7, 8, 9 and P2 : CS 10, 11, 
12, 13, 14, 15, 16). 
Antibody free bloodstream trypomasti-
gotes: in o rder t o suppress a n t i b o d y 
production, mice were treated with cyclophos-
phamide (350 mg/kg) 72 hours after having 
received intraperitoneally an infective dose of 3 
x 10 4 t r y p o m a s t i g o t e s . Seven days after 
infection the animals were bled by cutting the 
brachial plexus under light ether anaesthesia 
and the bloodstream trypomastigotes obtained 
as described by KRETTLI et a l . 7 with slight 
modifications: the blood was defibrinated with 
glass beads and the trypomastigote rich plasma 
separated by centrifugation for 10 min at 100 g. 
The parasites were then washed by centrifuga-
tion for 20 min at 1000 g with phosphate-
buffered saline (PBS) 0,15 M pH 7,2 containing 
10% normal mouse serum (NMS). To exclude 
the presence of membrane bound antibodies the 
t r y p o m a s t i g o t e were i n c u b a t e d wi th 
complement (fresh human serum) for 30 min at 
37°C. Only suspensions of parasites not lysed 
in the presence of complement were considered 
free of antibodies and were used to detect lytic 
antibodies. The final parasite suspension was 
adjusted with PBS containing 10% NMS to 4 x 
10 6 t rypomastigotes/ml. 
Test for lytic antibodies: the antibody lytic 
activity was determined by complement-
mediated lysis according to KRETTLI 5 with 
modificat ions. Twenty-five microliters of 
antibody free trypomastigotes suspension were 
added to 100 /il of serum from chagasic patients 
or isolated anti-T .cruzi antibodies and the 
mixtures incubated at 37°C for 30 min. After 
incubation aliquots of 25 ^1 each were removed, 
mixed with an equal volume of fresh normal 
human serum or inactivated serum from the 
same complement donor and further incubated 
at 37°C for 60 min. After that, the samples 
were immediately transferred to an ice bath, the 
number of motile trypomastigote determined in 
a Neubauer counting chamber and the 
percentage of lysis calculated. Duplicate 
samples were always used. 
Preparation of T. cruzi antigen for affinity 
chromatography: epimast igote antigen was 
obtained from T.cruzi culture in LIT medium 
at exponential growth phase containing more 
than 9 5 % epimastigotes. The cultures were 
centrifuged at 2000 g for 15 min at 4°C. The 
sediment was washed 4 times with PBS at 1500 
g for 15 min at 4°C. 
Trypomastigote antigen was prepared 
from trypomastigotes isolated from the blood 
of cyclophosphamide-treated immunosuppress-
ed mice as described in this paper. The isolated 
trypomastigotes were washed 3 times with PBS 
at 2000 g at 4°C. 
Both epimastigote and trypomastigote 
pellet containing about 10 1 0 parasites were 
resuspended in 10 ml of distilled water and 
sonicated at 60 Hz in a sonic dismembrator 
(Artex, Farmingdale, U.S.A.) for 2 min at 4°C, 
and centrifuged 30 min at 10.000 g. The 
sediment was discarded and the supernatant 
was lyophilized. This t reatment resulted in 
about 30 mg of material that was stored at 
-20°C. 
Conjugation of T . cruzi antigens to 
activated Sepharose 4B: t h r ee g r a m s of 
ac t iva ted Sepha rose 4B ( P h a r m a c i a Fine 
Chemicals; Uppsala, Sweden) were washed 3 
times with 50 ml of 10-3 N HC1. Thirty mg of 
lyophilized preparation were dissolved in 20 ml 
of 0,1 M N a H C 0 3 buffer containing 0,5 M NaCl 
and gently mixed with Sepharose 4B on a 
rotator at 4°C overnight. One ml of 1 M 
ethanolamine was then added for 1 hour at 
room temperature to inactivate active groups. 
The Sepharose was separated by filtration in a 
Buchner funnel and the absorbance of the 
f i l t ra te was de t e rmined at 280 n m . The 
percentage of conjugation was estimated based 
on the difference between the initial and final 
absorbance of antigen solution. Conjugation 
was usually over 8 0 % . The Sepharose was 
packed in a column and submitted to 3 washing 
cycles to remove any non-covalently bound 
protein; each cycle consisting of a wash at pH 
2,8 with 0,2
 t M glycine buffer containing 1 M 
NaCl followed by a wash at pH 8,0 with 0,1 M 
phosphate buffer containing 1 M NaCl. In 
order to check for specificity a similar column 
was prepared with Sepharose conjugated with 
bovine serum albumin (BSA). 
Isolation of lytic antibodies: lytic 
a n t i b o d i e s were i s o l a t e d by a f f in i ty 
chromatography using a 5 x 2 cm column of 
Sepharose conjugated with either trypomasti-
gote or epimastigote antigen preparations. One 
volume of serum from chagasic patients 
(usually 10 ml) was diluted in two parts of 
phosphate buffer (0,15 M pH 8,5) and slowly 
passed through the column under gravity force. 
The column was then washed with the same 
buffer until the optical density at 280 nm came 
to O. After passage through the column the 
serum from chagasic patients was restored to its 
original volume by positive pressure filtration. 
The antibodies were eluted with cold glycine 
buffer (0,2 M pH 2,8) while keeping the column 
jacketed in an ice-bath. 
Elution of the antibodies was followed by 
optical density at 280 nm. Two ml fractions 
were collected in glass tubes kept in an ice-bath 
and immediately neutralized with 1 M Tris 
buffer. The antibodies containing fractions 
were pooled, dialyzed against pH 7,4 PBS for 
24 hours and concentrated by positive pressure 
filtration to half the original serum volume. 
The isolated antibody was analysed regarding 
its isotype and lytic activity. 
RESULTS 
Samples of serum from chagasic patients 
were passed through an immunoadsorbent 
column containing either epimastigote or 
trypomastigote antigen and the lytic activity of 
the anti-T. cruzi antibodies eluted from each 
column was determined. The results of these 
experiments are shown in Table 1. It can be 
seen that sera from chagasic patients had their 
lytic activity decreased after passage tnrough 
the immunoadsorben t column and that 
antibodies eluted from either trypomastigote or 
epimastigote column were able to lyse trypo-
mastigotes in presence of complement. It can 
also be noted that in no case passage of the 
serum through either column caused complete 
removal of its lytic antibodies. Furthermore, 
even repeated passages of the chagasic serum 
through either the trypomastigote (Table 2) or 
the epimastigote column failed to completely 
remove its lytic activity. It can be further 
observed that passage of serum from chagasic 
patients through an immunoadsorbent column 
containing a non-related antigen such as BSA 
did not change its lytic activity (Table 1). In 
addition, it could also be observed that the 
material retained by the columns after passage 
of either sera from chagasic patients in BSA 
TABLE 1 
Lytic activity of ant ibodies isolated by affinity chromatography from serum of chagasic pat ients using immunoadsorben t 
co lumns containing t rypomast igote or epimast igote antigen. 
Sepharose 4B + Sepharose 4B + Sepharose 4B + 
trypomastigote antigen epimastigote antigen BSA 
% of Lysis % of Lysis % of Lysis 
Serum Samples CS 1 CS 2 CS 3 CS 1 CS 2 CS 3 CS 1 CS 2 CS 3 
Before 
Chromatography 95 81 70 95 81 70 95 81 70 
After passage 
in the column 6 8 56 43 57 65 33 92 85 70 
Ant ibodies 
eluted from the 
co lumn 
36 51 43 4 1 32 35 0 0 0 
Serum from chagasic pa t ien ts was passed through a co lumn of immunoadso rben t containing t rypomast igote , epimasti­
gote or BSA ant igen. After passage in the co lumn the serum samples, were re turned to their original volume by positive 
pressure f i l t rat ion. Ant ibodies were eluted wi th glycine buffer pH 2,8 neutralized and concent ra ted to half of the original 
serum volume by positive pressure fi l tration. The serum samples before and after passage through the column and the 
eluted ant ibodies were used t o sensitize t rypomast igotes for complement -media ted lysis. An immunoadsorbent column 
containing BSA was used as a cont ro l for specificity. 
TABLE 2 TABLE 3 
Removal of lytic ant ibodies by repeated passages of serum 
from chagasic pat ients through an fmmunoadsorben t 
column containing t rypomast igote antigen. 
% Lysis 
Sera from chagasic pa t ien ts : 
CS 4 CS 5 P I 
Before chromatography 95 94 81 
After 1st passage 76 67 67 
1st ant ibody 57 44 41 
After 2nd passage 70 63 63 
2nd ant ibody 0 0 0 
After 3rd passage 73 60 63 
3rd ant ibody 0 0 0 
10 ml of serum from chagasic pat ients were passed three 
times through an immunoadsorben t column containing 
t rypomast igote antigen. After each passage the serum was 
returned to its original vo lume by positive pressure filtra­
tion. The lytic activity of the serum samples and of the 
isolated antibodies was determined after each passage. 
Results shown here were obta ined using t rypomast igote 
antigen but similar results were also obta ined when 
epimastigote antigen was used. CS 4 and CS 5- sera from 
chagasic pat ients ; P 1, pool of serum from chagasic 
patients. 
Double absorpt ion of serum from chagasic pat ients with 
epimast igote and t rypomast igote antigens. 
% Lysis 
Before Chromatography 
After a single passage through 
epimast igote antigen 
After an addit ional passage 
through t rypomast igote 
antigen 
After a single passage through 
t rypomast igote antigen 
After an addit ional passage 
through epimast igote 
antigen 









Pool (P2) was first passed through the epimast igote 
co lumn and immediately after through the t rypomast i ­
gote co lumn or vice-versa. 
The lytic activity of the single and doubled passed serum 
samples and that of the eluted ant ibodies was determined. 
P 2 - pool of serum from chagasic pa t ien ts . 
column or normal sera in trypomastigote or 
epimastigote columns contained significantly 
less protein than the specific antibodies eluted 
after passage of sera from chagasic patients in 
trypomastigote or epimastigote columns as 
estimated by O.D. at 280 nm (results not 
shown). 
As shown in Table 2, a single passage of 
serum from chagasic patients through either 
t rypomast igote or epimast igote co lumn is 
sufficient to completely remove all the lytic 
antibodies able to react with antigens present 
on any one of these columns. In order to find 
out if a serum depleted of the antibodies able to 
react with one of the antigens would still have 
antibodies able to react with the other antigen, 
serum from chagasic patients was successively 
passed through both columns and its lytic 
activity determined after each passage. The 
results of these experiments depicted in Table 3 
showed that adsorption of serum from chagasic 
patients with one the antigens was sufficient to 
remove the antibodies able to react with the 
other antigen. 
Analysis of the antibodies isolated with 
epimastigote or trypomastigote antigen by 
immunodiffusion using monospecific antisera 
against human IgG, IgM, IgA, IgD and IgE 
showed that only IgG was present. 
DISCUSSION 
The experiments showing that antibodies 
with lytic activity can be removed from serum of 
Chagas ' disease patients by immunoadsorption 
with epimastigote antigen suggest strongly that 
lytic antibodies induced by infection are able to 
recognize epitopes present on epimastigote 
forms. The possibility that this adsorption 
could be due to contaminat ion of the 
epimastigote culture with metacyclic trypo-
mastigotes seems remote since the percentage of 
trypomastigote forms in our epimastigote 
preparation was very small (5%). Furthermore, 
if removal of lytic antibodies by epimastigote 
antigen were due to contamination with 
trypomastigote antigen, the removal capacity 
of the epimastigote columns should be much 
less than that of the trypomastigote column and 
yet the efficiency of both columns was very 
similar. 
The observat ion that even repeated 
passages through epimastigote and /o r trypo-
mastigote immunoadsorbent columns did not 
completely remove the lytic antibodies from 
serum from chagasic patients demonstrate that 
many other epitopes able to react with lytic 
antibodies are not present in our antigenic 
preparations. This is probably due to many 
different reasons one of them being the action 
of the many proteases present in the parasites. 
However, it must be considered that it does not 
matter how little denaturated is the parasite 
antigen preparation since the conjugation 
technique by itself causes a great deal of 
denaturation. This was no surprise and could 
not be overcame as we were unable to obtain a 
fully antigenic preparation from either form of 
the parasite. 
It is possible that the epitopes present on 
epimastigote and t rypomast igote antigen 
preparations able to react with lytic antibodies 
have the same or very similar antigenic 
structures since a single passage of serum from 
chagasic patients through one of these antigenic 
preparations was sufficient to completely 
remove the lytic antibodies able to react with 
the other ant igen. Indeed, when these 
antibodies were used to recognize epimastigote 
and trypomastigote antigen using the protein 
transfer technique 1 4 many common antigens 
were recognized on both parasite forms 
(unpublished results). 
In fact, previous studies on the antigenic 
composition of these forms have revealed the 
presence of many antigens common to all stages 
of the parasite although the existence of stage 
specific antigens has also been r e p o r t e d 1 1 - 1 5 - ] } . 
Recently, SNARY 1 0 isolated a T. cruzi celt 
surface glycoprotein of 90.000 M.W. able to 
protect mice against the acute phase of the 
infection that was present on all forms of the 
parasite. Furthermore, C H A O & DUSANIC^ 
working with hybridoma cell line secreting 
monoclonal antibodies against T. cruzi found 
that some of these monoclonals reacted with 
antigens present on both epimastigote and 
t r y p o m a s t i g o t e f o r m s . In fact , a l t h o u g h 
obtained by immunizat ion with metacyclic 
t rypomast igotes most of these monoclonal 
antibodies did not display a metacyclic stage 
specificity which indicated a considerable 
degree of ant igenic similarity a m o n g the 
different forms of T . cruzi. 
Our resul ts showing tha t " d e a d " 
trypomastigote antigens are still able to react 
with lytic antibodies seem contrary to the 
results of KRETTLI & BRENER 6 who reported 
t ha t lyt ic a n t i b o d i e s r eac t wi th l iving 
trypomastigotes but not with dead and fixed 
parasites. However, it is reasonable to think 
that treatment with fixatives denaturates the 
parasite antigens in a different and perhaps 
more drastic way than the technique for antigen 
extraction used here. Thus, fixation of parasites 
seems to destroy the ability of their antigens to 
react with lytic antibodies. 
K R E T T L I & B R E N E R 6 have a l so 
suggested that only an active infection is able to 
induce lytic antibodies. On the other hand, some 
recent reports showed that lytic antibodies can 
be induced after different immunization 
protocols using heat inactivated metacyclic 
t rypomastigotes 1 6 or even epimastigotes anti-
gens 9 . 
Our results showing that anti-T. cruzi lytic 
antibodies are mainly located in the IgG isotype 
agree with previous findings of ROMEIRO et 
a l . s who working with affinity chromatography 
with p ro te in A ob ta ined similar resul t s . 
Conversely, KIPNIS et a l . 4 have been able to 
obtain an IgM with lytic activity from sera of 
patients in the chronic phase of Chagas disease. 
We can of fer n o e x p l a n a t i o n for this 
discrepancy. 
These data and our present results suggest 
that more than one epitope present in the 
bloodstream trypomastigote is able to cause 
lysis of this parasite form on reaction with 
antibodies and that some of these epitopes are 
common to epimastigote culture forms. Further 
studies are required to elucidate this question. 
RESUMO 
Anticorpos líticos induzidos por infecção pelo 
Trypanosoma cruzi reconhecem epitopos 
presentes nas formas tripomastigotas e 
epimastigotas do parasita. 
Soro de pacientes com doença de Chagas 
na fase crônica foram submetidos a cromato-
grafia de afinidade com Sepharose 4B conjuga-
da com um extrato antigênico obtido de formas 
epimastigotas ou tripomastigotas de T. cruzi: 
os epimastigotas foram obtidos de cultura na 
fase exponencial de crescimento e os tripomas-
tigotas de sangue de camundongos infectados e 
imunossuprimidos. Os antígenos de ambas for-
mas parasitárias foram obtidos por t ratamento 
dos parasitas por ultra-som, seguido de centri-
fugação. 
A cromatografia de afinidade foi feita pas-
sando-se os soros chagásicos através de uma co-
luna de imunoadsorvente contendo antígenos 
de epimastigotas ou tripomastigotas. Os anticor-
pos foram eluídos da coluna com tampão glici-
na 0,2 M pH 2,8 a 4°C. Os anticorpos eluidos 
foram analisados quanto ao seu isotipo e ativi-
dade lítica. Os resultados mostraram que os an-
ticorpos anti-T. cruzi com atividade lítica pre-
sentes em soros chagásicos estão localizados no 
isotipo IgG e reconhecem epitopos presentes 
tanto nos tripomastigotas quanto nos epimasti-
gotas. 
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